← 홈

CGT

1,235개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,235개
CGTBiologiciCell Gene TherapeuticsPhase 1

TCR (E6 T Cell Receptor, E6 T Cell Receptor (TCR))

Human Papillomavirus; HPV-16 · Human Papillomavirus

#HumanPapillomavirus#CGT#Phase1#인기#세포유전치료+5
효능 ORR 50%임상시험 61상태 DISCONTINUED
CGTBiologicAstraZenecaPhase 2

Epidermal growth factor receptor (EGFRv, Epidermal growth factor receptor, Epidermal growth factor receptor(EGFRv)III Chimeric antigen receptor (CAR) transduced PBL)

Malignant Glioma; Glioblastoma · EGFR

#EGFR#CGT#Phase2#인기#세포유전치료+5
효능 ORR 68%임상시험 61상태 ACTIVE
CGTBiologicGlaxoSmithKlineSN-38 also augmented IL-10 …Phase 2

topotecan hydrochloride (topotecan hydrochloride)

Fallopian Tube Carcinosarcoma; Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 95.4%임상시험 61상태 DISCONTINUED
CGTBiologicSinobioway Cell Therapy Co., Lt…Preclinical

CD19-targeted CAR-T cells (CD19-targeted CAR-T cells)

Lymphoma · CD19

#CD19#CGT#Preclinical#인기#세포유전치료+5
효능 ORR 94%임상시험 60상태 ACTIVE
CGTBiologicEpicentRx, Inc.Phase 2

Checkpoint Inhibitor, Immune (Checkpoint Inhibitor, Immune)

Solid Tumor, Adult; Cancer · Solid Tumor, Adult

#SolidTumorAdult#CGT#Phase2#인기#세포유전치료+5
효능 ORR 59%임상시험 60상태 RECRUITING
CGTBiologicBellicum PharmaceuticalssPhase 2

Chimeric antigen receptor (CAR, Chimeric antigen receptor, Chimeric antigen receptor (CAR) T-cell therapy)

Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#CGT#Phase2#인기#세포유전치료+4
효능 ORR 80.3%임상시험 60상태 RECRUITING
CGTBiologicTransMolecularPhase 1

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery))

Recurrent Glioblastoma; Recurrent Malignant Glioma · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5
임상시험 60상태 RECRUITING
CGTBiologicTransMolecularPhase 1

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery))

Recurrent Glioblastoma; Recurrent Malignant Glioma · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5
임상시험 60상태 RECRUITING
CGTBiologicAmerican Gene Technologies Inte…sPreclinical

Gene modified therapy (Gene modified therapy)

HIV · HIV

#HIV#CGT#Preclinical#인기#세포유전치료+4
효능 ORR 41.6%임상시험 60상태 ACTIVE
CGTBiologicNational Heart, Lung, and Blood…Phase 2

Haploidentical Hematopoietic Cell Transplantation (Haploidentical Hematopoietic Cell Transplantation)

Hemoglobinopathy (Disorder); Severe Aplastic Anemia · Primary Immune Deficiency Disorders

#PrimaryImmuneDeficiencyDisorders#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 RECRUITING
CGTBiologicMedigene AGPhase 2

Lymphodepletion (Lymphodepletion)

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · FRα

#FR#CGT#Phase2#인기#세포유전치료+5
효능 0%임상시험 60상태 DISCONTINUED
CGTBiologicTurnstone Biologics, Corp.Phase 1

RT-01 (Oncolytic Virus Injection, Oncolytic Virus Injection(RT-01))

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#인기#세포유전치료+4
효능 ORR 28%임상시험 60상태 ACTIVE
CGTBiologicLion TCR Pte. Ltd.Phase 1

TCR-T (TCR-T)

Chronic Hepatitis B · Chronic Hepatitis B

#ChronicHepatitisB#CGT#Phase1#인기#세포유전치료+4
효능 ORR 50%임상시험 60상태 ACTIVE
CGTBiologicAbbottvedotinPhase 2

Zidovudine (Zidovudine)

Lymphoproliferative Disorder; HHV-8 · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 RECRUITING
CGTBiologicSabz BiomedicalsPhase 2

cytokine-induced killer cell (cytokine-induced killer cell)

Colon Cancer Stage IV · Solid Tumors

#SolidTumors#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 ACTIVE
CGTBiologicGamma Medica-IdeasPhase 2

tamoxifen citrate (tamoxifen citrate)

Male Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 13%임상시험 60상태 ACTIVE
CGTBiologicCelgenevedotin (BV) maintenance th…Phase 2

ASCT (ASCT)

Multiple Myeloma; Newly Diagnosed · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#인기#세포유전치료+5
효능 ORR 11%임상시험 59상태 RECRUITING
CGTBiologicAbClonvedotin-containing regimens…Phase 2

Anti-CD19 Chimeric Antigen Receptor T cell (AT101, AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 38%임상시험 59상태 RECRUITING
CGTBiologicMerck Sharp & Dohme LLCPhase 2

Interferon-alpha (Interferon-alpha)

Lymphoproliferative Disorder; HHV-8 · Lymphoproliferative Disorder

#LymphoproliferativeDisorder#CGT#Phase2#인기#세포유전치료+5
임상시험 59상태 RECRUITING
CGTBiologicImmunityBio, Inc.sPhase 2

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#인기#세포유전치료+4
임상시험 59상태 DISCONTINUED

3 / 62 페이지

← 이전다음 →